Rod metabolic demand drives progression in retinopathies
- PMID: 29018679
- PMCID: PMC5602704
- DOI: 10.1016/j.tjo.2015.06.002
Rod metabolic demand drives progression in retinopathies
Abstract
Various factors are thought to cause the development and progression of disease in macular degeneration, diabetic retinopathy, and retinitis pigmentosa. Some of the deleterious processes include oxidative stress, hypoxia, metabolic derangement, genetics, and vasculopathy. In this review, we present a unified theory for the pathophysiology of several retinopathies based on the unique and intense metabolism of rod photoreceptors.
Keywords: SIRT6; diabetic retinopathy; macular degeneration; metabolism; retinitis pigmentosa.
Conflict of interest statement
Conflicts of interest: The authors report no conflicts of interest in this work.
Figures

Similar articles
-
Beneficial effect of antioxidants in retinopathies: a new hypothesis.Med Hypothesis Discov Innov Ophthalmol. 2012 Winter;1(4):76-9. Med Hypothesis Discov Innov Ophthalmol. 2012. PMID: 24600629 Free PMC article.
-
Novel stem cell and gene therapy in diabetic retinopathy, age related macular degeneration, and retinitis pigmentosa.Int J Retina Vitreous. 2019 Feb 13;5:7. doi: 10.1186/s40942-019-0158-y. eCollection 2019. Int J Retina Vitreous. 2019. PMID: 30805203 Free PMC article. Review.
-
A diffusible factor from normal retinal cells promotes rod photoreceptor survival in an in vitro model of retinitis pigmentosa.J Neurobiol. 1999 Jun 15;39(4):475-90. J Neurobiol. 1999. PMID: 10380070
-
Retinitis Pigmentosa and Other Dystrophies.Dev Ophthalmol. 2017;58:191-201. doi: 10.1159/000455281. Epub 2017 Mar 28. Dev Ophthalmol. 2017. PMID: 28351048
-
Metabolism and Vascular Retinopathies: Current Perspectives and Future Directions.Diagnostics (Basel). 2022 Apr 5;12(4):903. doi: 10.3390/diagnostics12040903. Diagnostics (Basel). 2022. PMID: 35453951 Free PMC article. Review.
Cited by
-
Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration.J Clin Invest. 2016 Dec 1;126(12):4659-4673. doi: 10.1172/JCI86905. Epub 2016 Nov 14. J Clin Invest. 2016. PMID: 27841758 Free PMC article.
-
Gene-agnostic therapeutic approaches for inherited retinal degenerations.Front Mol Neurosci. 2023 Jan 9;15:1068185. doi: 10.3389/fnmol.2022.1068185. eCollection 2022. Front Mol Neurosci. 2023. PMID: 36710928 Free PMC article. Review.
-
CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa.Cell Rep Med. 2024 Apr 16;5(4):101459. doi: 10.1016/j.xcrm.2024.101459. Epub 2024 Mar 21. Cell Rep Med. 2024. PMID: 38518771 Free PMC article.
-
Perspectives on Gene Therapy: Choroideremia Represents a Challenging Model for the Treatment of Other Inherited Retinal Degenerations.Transl Vis Sci Technol. 2020 Feb 14;9(3):17. doi: 10.1167/tvst.9.3.17. Transl Vis Sci Technol. 2020. PMID: 32714643 Free PMC article.
-
Treatment of Macular Degeneration with Sildenafil: Results of a Two-Year Trial.Ophthalmologica. 2018;240(1):45-54. doi: 10.1159/000486105. Epub 2018 Apr 25. Ophthalmologica. 2018. PMID: 29694963 Free PMC article. Clinical Trial.
References
-
- Nakanishi S. Second-order neurones and receptor mechanisms in visual- and olfactory-information processing. Trends Neurosci. 1995;18:359–364. - PubMed
-
- Yau KW, Hardie RC. Phototransduction motifs and variations. Cell. 2009 Oct 16;139(2):246–264. http://dx.doi.org/10.1016/j.cell.2009.09.029 . - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources